Da Zen Theranostics

Da Zen Theranostics, Inc. has been granted exclusive global IP licenses by two top medical research institutions to develop and commercialize new therapeutics for cancer. The product of over 10 years of laboratory work, the portfolio of six patents licensed by Da Zen are all related to cancer detection and treatment. Da Zen's drugs will do more tha... n just kill cancer cells and prevent cancer metastasis. Because of their unique properties, they will also help overcome therapeutic resistance. Unlike traditional chemotherapy, Da Zen's new medical technology will target ONLY primary and metastatic cancer cells without damaging normal tissues and organs. Furthermore, the Company is developing new diagnostic biomarkers that can differentiate between responsive and unresponsive tumors, which greatly increases the chance of success because it allows for more accurate patient selection. In addition to the licensed IP, the Company does its own drug research and has filed its own unique patent applications. Currently, the Company has received funding for preclinical IND work and intends to proceed to human clinical trials in 2020. Please contact the company to see how the company can partner to develop cancer treatment solutions for you.Read More